Tislelizumab Combined With Chemotherapy for Different Cycles of Neoadjuvant Therapy for Locally Advanced Resectable Squamous Cell Carcinoma of the Head and Neck (NeoTempo)

NCT07147426 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Head &Amp; Neck Squamous Cell Carcinoma

Interventions

DRUG: Tislelizumab Combined With Chemotherapy for 4 cycles
DRUG: Tislelizumab Combined With Chemotherapy for 2 cycles

Sponsor

Tianjin Medical University Cancer Institute and Hospital